When cancer surgery is advised, the choice between robotic and traditional open surgery can raise an important question: is the added cost of robotic surgery actually worth paying?
Cancer surgery is planned around the type, stage and location of the cancer, the structures involved, the patient's overall health and the surgeon's assessment. Robotic surgery can offer important advantages in selected cases, but it is not automatically the better choice for every cancer or every patient.
Traditional surgery, usually referred to as open surgery, involves making an incision large enough for the surgeon to directly access the tumour and surrounding structures. Depending on the cancer, the operation may involve removing the tumour along with a margin of surrounding healthy tissue and, where appropriate, nearby lymph nodes.
Open surgery remains an important part of cancer treatment. It can provide the surgeon with direct access and a broad view of the operative field, and it continues to be the preferred approach for some complex cancers and situations where minimally invasive surgery is unsuitable.
The decision is based on what provides the safest and most effective cancer removal, rather than simply on the size of the incision.
Robotic cancer surgery is a form of minimally invasive surgery. Instead of one large incision, the surgeon generally operates through several small incisions using specialised instruments attached to robotic arms.
The robot does not operate independently. The surgeon controls the robotic system throughout the procedure. A high-definition camera provides a magnified, three-dimensional view of the surgical field, while the system translates the surgeon's hand movements into precise movements of the instruments.
This can be particularly useful when operating in confined anatomical areas, such as the pelvis or certain regions of the head and neck.
The principal difference is how the surgeon reaches and operates on the tumour.
Minimally invasive approaches generally involve smaller incisions and can shorten recovery compared with open surgery, although the actual benefit depends greatly on the cancer and procedure being performed.
This is where it is important to look beyond the technology. Robotic surgery is not inherently more effective at treating cancer simply because a robot is used. The main goal remains complete and appropriate removal of the cancer while preserving important surrounding structures wherever medically possible.
For some cancers and operations, robotic surgery can provide useful short-term benefits such as reduced blood loss, less postoperative discomfort and shorter hospitalisation. However, the long-term cancer outcomes of robotic and open surgery can be similar when the procedure is appropriately selected and performed by an experienced team. The evidence also varies between cancer types.
For example, minimally invasive surgery is not appropriate for every cancer operation. Certain procedures may have specific evidence favouring open surgery, which is why the surgical approach should be decided case by case.
The additional cost generally reflects the technology and resources involved. Depending on the hospital and procedure, the overall price may include:
The final cost also varies according to the type and stage of cancer, complexity of surgery, hospitalisation, investigations, medicines, consumables and whether additional treatment is required. Therefore, a fixed price cannot be applied to all robotic cancer surgeries.
For a suitable patient, the additional expense may be worth discussing when robotic surgery offers a meaningful advantage in surgical access or recovery.
This can be particularly relevant for operations involving anatomically narrow or difficult-to-reach areas. At the same time, if open surgery provides better access or is considered oncologically safer for a particular tumour, choosing the more expensive robotic option would serve little purpose.
The question to ask is therefore not simply, "Is robotic surgery better?" It is: "For my cancer, does robotic surgery offer a meaningful advantage without compromising the effectiveness of treatment?"
At STAR Hospitals, Hyderabad, surgical oncology is supported by a multidisciplinary team that performs complex cancer operations using open, laparoscopic and robotic approaches where clinically appropriate. STAR's Surgical Oncology department reports experience in complex cancer surgeries and uses techniques including robotic surgery, minimally invasive procedures, sentinel lymph-node mapping, thoracoscopic lung surgery and intraoperative imaging.
STAR Hospitals also has a dedicated Institute of Robotic Surgeries, equipped with the Da Vinci Xi Robotic Surgical System. The robotic programme covers multiple specialties, with robotic surgery used under the control of trained surgeons rather than as an autonomous system.
To know more and discuss your options, book an appointment today.
The surgical oncology team includes specialists experienced in robotic and laparoscopic cancer surgery across areas such as head and neck, gastrointestinal, gynaecological, genitourinary, breast and soft-tissue cancers.
It can be—for the right patient and the right cancer operation.
Robotic surgery can offer smaller incisions and useful recovery advantages in selected procedures, while open surgery remains an essential and highly effective approach for many cancers. The skill and experience of the cancer surgeon, appropriate patient selection and the ability to achieve sound cancer control matter more than the presence of a robot alone.
If you have been advised to undergo cancer surgery, ask your surgical oncologist why a particular approach has been recommended, what the alternatives are, how they may affect recovery and what the expected total cost will be. A careful discussion can help you choose an approach that balances cancer control, safety, recovery and affordability